{{Rsnum
|rsid=2072454
|Gene=EGFR
|Chromosome=7
|position=55146655
|Orientation=plus
|GMAF=0.4545
|Gene_s=EGFR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 21.2 | 49.6 | 29.2
| HCB | 30.7 | 55.5 | 13.9
| JPT | 46.0 | 46.0 | 8.0
| YRI | 26.5 | 51.7 | 21.8
| ASW | 24.6 | 52.6 | 22.8
| CHB | 30.7 | 55.5 | 13.9
| CHD | 34.9 | 53.2 | 11.9
| GIH | 13.9 | 49.5 | 36.6
| LWK | 37.6 | 45.0 | 17.4
| MEX | 25.9 | 51.7 | 22.4
| MKK | 27.6 | 53.2 | 19.2
| TSI | 29.4 | 50.0 | 20.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=22552271
|Title=Integrated effect of EGFR and PAR-1 signaling crosstalk on airway hyperresponsiveness
}}

{{PMID Auto
|PMID=17598910
|Title=Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=17956637
|Title=Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}